Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP209340.RAFvu6wWpO8dzPcdEx80TmQ11ey9CS9VD7ZV0Wv3k27Is130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP209340.RAFvu6wWpO8dzPcdEx80TmQ11ey9CS9VD7ZV0Wv3k27Is130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP209340.RAFvu6wWpO8dzPcdEx80TmQ11ey9CS9VD7ZV0Wv3k27Is130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP209340.RAFvu6wWpO8dzPcdEx80TmQ11ey9CS9VD7ZV0Wv3k27Is130_provenance.
- NP209340.RAFvu6wWpO8dzPcdEx80TmQ11ey9CS9VD7ZV0Wv3k27Is130_assertion description "[The mice were found to exhibit vIL-6 serum levels comparable with those observed in HHV-8-infected patients, to contain elevated amounts of phosphorylated STAT3 in spleen and lymph nodes, where vIL-6 was produced, and to spontaneously develop key features of human plasma cell-type MCD, including splenomegaly, multifocal lymphadenopathy, hypergammaglobulinemia, and plasmacytosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP209340.RAFvu6wWpO8dzPcdEx80TmQ11ey9CS9VD7ZV0Wv3k27Is130_provenance.
- NP209340.RAFvu6wWpO8dzPcdEx80TmQ11ey9CS9VD7ZV0Wv3k27Is130_assertion evidence source_evidence_literature NP209340.RAFvu6wWpO8dzPcdEx80TmQ11ey9CS9VD7ZV0Wv3k27Is130_provenance.
- NP209340.RAFvu6wWpO8dzPcdEx80TmQ11ey9CS9VD7ZV0Wv3k27Is130_assertion SIO_000772 22490805 NP209340.RAFvu6wWpO8dzPcdEx80TmQ11ey9CS9VD7ZV0Wv3k27Is130_provenance.
- NP209340.RAFvu6wWpO8dzPcdEx80TmQ11ey9CS9VD7ZV0Wv3k27Is130_assertion wasDerivedFrom befree-20140225 NP209340.RAFvu6wWpO8dzPcdEx80TmQ11ey9CS9VD7ZV0Wv3k27Is130_provenance.
- NP209340.RAFvu6wWpO8dzPcdEx80TmQ11ey9CS9VD7ZV0Wv3k27Is130_assertion wasGeneratedBy ECO_0000203 NP209340.RAFvu6wWpO8dzPcdEx80TmQ11ey9CS9VD7ZV0Wv3k27Is130_provenance.
- befree-20140225 importedOn "2014-02-25" NP209340.RAFvu6wWpO8dzPcdEx80TmQ11ey9CS9VD7ZV0Wv3k27Is130_provenance.